Kite Pharma, a Gilead company, described a new method to characterize individual lentiviral vector particles using flow virometry. The approach is designed to improve understanding of in vivo CAR T vector quality by mapping surface protein distributions at single-particle resolution, supporting better batch-to-batch consistency. Meanwhile, Northwestern University secured $30 million from the NSF to establish GENIE, a new center for 3D genome geometry research. The effort targets DNA folding as a lever in health and disease, with technology development intended to help cells withstand damage and restore function—supporting longer-horizon translational biology.